Please join us September 4-5 for the 14th Annual Wells Fargo Securities Healthcare Conference in Boston.

The conference will consist of select company presentations and customized one-on-one meetings with senior executives from leading Healthcare Companies.

Please review the information below as you prepare for the conference and contact us with any questions.

 
Agenda

Please scroll down for a detailed agenda.

Wednesday, September 4

7:00 a.m.
Breakfast and registration - Essex Ballroom Foyer, 3rd Floor

8:00 a.m. - 5:00 p.m.
Company Presentations / Fireside Chats, scheduled one-on-ones and group meetings

12:00 p.m.
Keynote Lunch - Dr. Gilbert H. Kliman, Managing Director,  Interwest Partners - Future of Ophthalmology Devices
 
 
Thursday, September 5

7:00 a.m.
Breakfast and registration - Essex Ballroom Royer, 3rd Floor

8:00 a.m. - 5:00 p.m.
Company Presentations / Fireside Chats, scheduled one-on-ones and group meetings
 
12:05 p.m.
Keynote Lunch - Andrew Witty, Office of the Chief Executive, Executive Vice President, UnitedHealth Group, Chief Executive Officer, Optum


Investor one-on-ones

We will be hosting one-on-one meetings in 30 minute slots.  Please submit one-on-one requests when registering online, or contact your Wells Fargo Securities representative.


Participating Companies
* as of September 3
*  Abbott Laboratories (ABT) - Scott Leinenweber, VP, IR, Licensing & Acquisitions;  Laura Dauer, Director, Investor Relations
*  Acadia Healthcare Company, Inc. (ACHC) - Debbie Osteen, CEO; David Duckworth, CFO; Gretchen Hommrich, Director, IR
*  Affimed (AFMD) - Adi Hoess, CEO; Gregory Gin, Head of IR 
*  Aimmune Therapeutics (AIMT) - Eric Bjerkholt, CFO; DeDe Sheel, VP, IR 
*  Akouous, Inc. (Private) - Emmanuel Simons, President & CEO
*  Alcon Inc. (ALC) - David Endicott, CEO; Karen King, SVP, Head Global IR & Communications; Rafael Lopes, Investor Relations
*  Alder Biopharmaceuticals (ALDR) - Carlos Campoy, CFO; Erin Lavelle, COO
*  Allscripts Healthcare Solutions, Inc. (MDRX) - Paul Black, CEO; Stephen Shulstein, VP, IR
*  Amphastar Pharmaceuticals Inc. (AMPH) - Jason Shandell, President; Bill Peters, CFO
*  Anthem, Inc. (ANTM) - John Gallina, EVP & CFO; Chris Rigg, VP, Investor Relations & Corporate Finance; Paige Kerns, Director, IR
*  Applied Genetic Technologies (AGTC) - Sue Washer, President & CEO; Theresa Heah, M.D., M.B.A., Chief Medical Officer; Stephen Potter, Chief Business Officer
*  Arena Pharmaceuticals (ARNA) - Amit Munshi, President & CEO; Kevin Lind, EVP & CFO
*  Ascendis Pharma (ASND) - Jan Mikkelsen, CEO; Scott Smith, CFO; Patti Bank, IR
*  Autolus Therapeutics plc (AUTL) - Christian Itin, CEO; Andrew Oakley, CFO; Susan Noonan, IR
*  Aveta Biomics, Inc. (Private) - Parag Mehta, CEO
*  AVROBIO, Inc. (AVRO) - Geoff MacKay, CEO; Erik Ostrowski, CFO; Chris Mason, CSO
*  Axonics Modulation Technologies Inc. (AXNX) - Raymond W. Cohen, CEO; Dan Dearen, President & CFO
*  Baxter International Inc. (BAX) - Jay Saccaro, EVP & CFO; Clare Trachtman, VP, Investor Relations
*  Becton, Dickinson and Company (BDX) - Tom Polen, President & COO; John Gallagher, SVP, CFO, Medical Segment & Treasurer FP&A; Herman Cueto, SVP & CFO BD Interventional, FP&A; Anthony Di Meo, Sr. Director Investor Relations
*  Bellicum Pharmaceuticals (BLCM) - Richard Fair, President & CEO; Atabak Mokari, CFO
*  BenefitFocus, Inc. (BNFT) - Raymond August, President & CEO; Steve Swad, CFO; Michael Bauer, SR Director Finance & IR
*  BioDelivery Sciences International (BDSI) - Herm Cukier, CEO; Terry Coelho, CFO; Mary Coleman, Vice President, Investor Relations
*  Biohaven Pharmaceutical Holding Co Ltd (BHVN) - Vlad Coric, CEO; Jim Engelhart, CFO
*  Boston Scientific Corporation (BSX) - Michael Mahoney, CEO;   Susan Lisa, Vice President, IR
*  Calithera Biosciences (CALA) - Susan Molineaux, Founder, President & CEO;  Keith Orford, Chief Medical Officer;  Stephanie Wong, SVP of Finance and Secretary; Jennifer McNealey, VP of Investor Relations and Strategy
*  Cellectis SA (CLLS) - Andr?Choulika, Chairman & CEO;  Simon Harnest, Vice President, Corporate Strategy & Finance
*  Celyad (CYAD) - Filippo Petti, CEO; Anne Moore, VP, Strategy
*  Centene Corporation (CNC) - Ed Kroll, SVP, Finance and IR Erica Silver, Director, IR
*  Cerner Corporation (CERN) - Marc Naughton, EVP & CFO; Allan Kells, SVP, IR
*  CIGNA Corp. (CI) - Eric Palmer, EVP & CFO; William McDowell, Vice President, Investor Relations; Frederick Manning, Investor Relations
*  Clovis Oncology, Inc. (CLVS) - Patrick Mahaffy, President & CEO; Breanna Burkart, VP, IR & Corporate Communications
*  Computer Programs & Systems Inc. (CPSI) - Matt Chambless, CFO
*  Conformis Inc. (CFMS) - Mark Augusti, President & CEO; Paul Weiner, CFO
*  Cooper Companies, Inc. (COO) - Al White, President & CEO
*  CRISPR Therapeutics (CRSP) - Susie Kim, VP, Corporate Communications & IR; Claudia Styslinger, Investor Relations
*  Edwards Lifesciences Corporation (EW) - Mike Mussallem, Chairman & CEO; Scott Ullem, Corporate VP & CFO; Todd Brinton, Corporate VP, Advanced Technology & Chief Scientific Officer;  Mark Wilterding, - VP of IR
*  Ellex (ELXMF) - Tom Spurling, CEO; Maria Maieli, CFO
*  Emergent BioSolutions Inc. (EBS) - Robert Kramer, President and CEO; Richard Lindahl, EVP, CFO
*  Encompass Health (EHC) - Mark Tarr, President & CEO; Doug Coltharp, EVP & CFO; Crissy Carlisle, Chief Investor Relations Officer
*  Evofem Biosciences (EVFM) - Saundra Pelletier, CEO; Russ Barrans, Chief Commercial Officer; Kelly Culwell, Chief Medical Officer; Amy Raskopf, Head of Investor Relations
*  Evolent Health (EVH) - Frank William, CEO; John Johnson, CFO; Nicky McGrane, EVP, Corporate Performance
*  Evolus Inc. (EOLS) - David Moatazedi, President & Chief Executive Office; Lauren Silvernail, CFO & EVP, Corporate Development; Ashwin Agarwal, VP Finance, IR & Treasury; Kaitlyn Brosco, Investor Relations; Tram Bui, Investor Relations
*  Fate Therapeutics, Inc. (FATE) - Scott Wolchko, CEO; Dan Shoemaker, CSO
*  Five Prime Therapeutics (FPRX) - Aron Knickerbocker, CEO; Helen Collins, CMO; Martin Forrest, VP, Investor Relation & Corp Comm
*  Flexion Therapeutics, Inc. (FLXN) - Michael Clayman, CEO; David Arkowitz, CFO; Scott Young, VP of Corp. Comms & IR
*  Glaukos Corporation (GKOS) - Tom Burns, President & CEO; Joe Gilliam, CFO;  Chris Calcaterra, COO;  Chris Lewis, IR
*  Globus Medical, Inc. (GMED) - Dan Scavilla, EVP & CCO; Keith Pfeil, SVP & CFO; Brian Kearns, Sr. VP Business Development
*  Halozyme Therapeutics (HALO) - Helen Torley, CEO; Albert Kildani, Investor Relations
*  Hanger Inc. (HNGR) - Vinit Asar, President & CEO; Tom Kiraly, EVP & CFO; Seth Frank, VP Treasury & Investor Relations
*  HCA Healthcare Inc. (HCA) - Bill Rutherford, EVP & CFO; Mark Kimbrough, VP, Investor Relations
*  HealthEquity, Inc. (HQY) - Jon Kessler, President & CEO; Darcy Mott, EVP & CFO; Tyson Murdock, SVP & Controller; Richard Putnam, IR
*  HMS Holdings Corporation (HMSY) - Jeff Sherman, CFO; Robert Borchert, Investor Relations
*  Hookipa Pharma (HOOK) - Joern Aldag, CEO; Igor Matushansky, MD, PhD, CMO; Matt Beck, Executive Director, IR;  Susan Noonan, IR
*  Humana Inc. (HUM) - Bruce Broussard, CEO; Lisa Stoner, Director, Investor Relations
*  Immunomedics, Inc. (IMMU) - Behzad Aghazadeh, Executive Chairman; Usama Malik, CFO & Chief Business Officer; Chau Cheng, Sr. Director, IR
*  Impulse Dynamics (Private) - Simos Kedikoglou, CEO; Gerald Haines, CFO
*  IMV, Inc. (IMV) - Frederic Ors, CEO; Pierre Labbe, CFO
*  Infinity Pharmaceuticals (INFI) - Lawrence Bloch, President; Adelene Perkins, Chairman & CEO; Jeff Kutok, Chief Scientific Officer
*  Inspire Medical Systems, Inc. (INSP) - Tim Herbert, President & CEO; Rick Buchholz, CFO
*  Integra LifeSciences Holdings Corporation (IART) - Carrie Anderson, CFO; Glenn Coleman, Chief Operations Officer; Michael Beaulieu, Director, IR; Sravan Emany, SVP-Strategic Initiatives, Treasury & IR
*  Intuitive Surgical, Inc. (ISRG) - Marshall Mohr, EVP & CFO; Calvin Darling, Sr. Director, IR
*  IONIS Pharmaceuticals, Inc. (IONS) - Beth Hougen, CFO; Wade Walke, VP of Investor Relations 
*  Iovance Biotherapeutics (IOVA) - Timothy Morris, CFO
*  Ironwood Pharmaceuticals, Inc. (IRWD) - Mark Mallon, CEO; Gina Consylman, CFO; Meredith Kaya, VP, Investor Relations and Communications; Garret Bonney, Manager Investor Relations
*  Jazz Pharmaceuticals Plc (JAZZ) - Daniel Swisher, President & COO; Diane Schrick, Senior Director, Investor Relations
*  Johnson & Johnson (JNJ) - Ashley McEvoy, EVP, Worldwide Chairman, Medical Devices; Jon Pais, Senior Manager; Chris DelOrefice, VP, Investor Relations; Matt Stuckley, Sr. Director, IR
*  Jounce Therapeutics (JNCE) - Richard Murray, Ph.D., CEO & President; Kim Drapkin, CFO; Elizabeth Trehu, MD, CMO; Komal Joshi, Investor Relations & Strategic Finance
*  Kala Pharmaceuticals, Inc. (KALA) - Mark Iwicki, Chairman & CEO; Mary Reumuth, CFO; Todd Bazemore, COO; Niranjan Kameswaran, VP, Strategy
*  Karuna Therapeutics Inc. (KRTX) - Steve Paul, CEO; Troy Ignelzi, CFO; Jason Brown, VP, Finance
*  Kezar Life Sciences (KZR) - John Fowler, CEO;  Christopher Kirk, CSO; Celia Economides, SVP, Strategy and External Affairs
*  Lantheus Holdings, Inc. (LNTH)- Mary Anne Heino, President & CEO; Robert Marshall, CFO & Treasurer; Mark Kinarney, Director, IR
*  LeMaitre Vascular Inc. (LMAT) - JJ Pellegrino, CFO
*  Lexicon Pharmaceuticals, Inc. (LXRX) - Jeff Wade, EVP & CFO; Pablo Lapuerta, EVP, Chief Medical Officer; Kim Lee, Exec. Director, Investor Relations & Strategy
*  Mallinckrodt Plc (MNK) - Mark Trudeau, President & CEO; Bryan Reasons, EVP & CFO; Steve Romano, M.D., EVP & Chief Scientific Officer; Daniel Speciale, VP, Investor Relations and IRO
*  MAXIMUS, Inc. (MMS) - Bruce Caswell, CEO; Matthew Burns, Investor Relations Manager
*  MediWound Ltd. (MDWD) - Sharon Malka, CEO
*  Medtronic plc (MDT) - Michael Coyle, EVP & President, Cardiac & Vascular Group; Ryan Weispfenning, VP IR; Wynne Edgson, Director, IR
*  MEI Pharma (MEIP) - Dan Gold, Ph.D, CEO;  David Walsey, VP
*  Merit Medical Systems (MMSI) - Fred Lampropolous, Chairmain & CEORaul Parra CFO
*  Moderna, Inc. (MRNA) - Lorence Kim, CFOLavina Talukdar, Head of Investor Relations
*  Momenta Pharmaceuticals, Inc. (MNTA) -  Craig Wheeler, CEO; Michelle Robertson,CFO; Young Kwon, Chief Business Officer; Patty Eisenhaur, VP, Investor Relations
*  Morphic Holding, Inc. (MORF) - Praveen Tipirneni, President & CEO
*  Mustang Bio, Inc. (MBIO) - Manny Litchman, President & CEO
*  MyoKardia, Inc. (MYOK) - Taylor Harris, CFO; Bill Fairey, Chief Commercial Officer
Marc Semigran, SVP, Medical Sciences; Michelle Corral, Head of IR and Corporate Communications
*  Natus Medical Inc. (NTUS) - Drew Davies, CFO
*  Neos Therapeutics, Inc. (NEOS) - Jerry McLaughlin, CEO and Director; Richard Eisenstadt, CFO
*  Novartis AG (NVS) - Sloan Simpson, North America Head of Investor Relations
Cory Twining, Investor Relations Officer
*  NovoCure Limited (NVCR) -
Wilco Groenhuysen, CFO; Ashley Cordova, SVP, Finance and IR; Gabrielle Fernandes, Associate Director, IR
*  NuVasive Inc (NUVA) - Chris Barry, CEO; Suzanne Hatcher, Vice President, Internal & External Affairs
*  Ocular Therapeutix Inc (OCUL) - Antony Mattessich, CEO; Donald Notman, CFO
*  Omnicell, Inc. (OMCL) - Randall Lipps, Chairman, President, CEO &  Founder; Peter Kuipers, EVP, CFO
*  OMNIlife Science (Private) - Rick Epstein, CEO
*  Opiant Pharma (OPNT) - Roger Crystal, M.D., CEO; David O?oole, CFO; Lisa Sher, Senior Director, IR and Communications
*  Osmotica Pharmaceuticals plc. (OSMT) - Brian Markison, CEO; Andrew Einhorn, CFO
*  Oxford Immunotec Global PLC (OXFD) - Peter Wrighton-Smith, CEO; Matt McLaughlin, CFO
*  Penumbra, Inc. (PEN) - Adam Elsesser,President & CEO; Sri Kosaraju, CFO & Head of Strategy; Jee Hamlyn-Harris, Investor Relations
*  Precision Biosciences (DTIL) - Matt Kane, CEO
*  Premier, Inc. (PINC) - Adam Elsesser,President & CEO; Sri Kosaraju, CFO & Head of Strategy; Jee Hamlyn-Harris, Investor Relations
*  Principia Biopharma Inc. (PRNB) - Martin Babler, CEO; Christopher Chai, CFO; Alex Sharif, Director, IR and Business Development
*  Regulus Therapeutics (RGLS) - Joseph Hagan, CEO; Daniel Chevallard, CFO
*  Relay Therapeutics (Private) - Sanjiv Patel, President & CEO; Imogen Pryce, VP, Strategy & Corporate Affairs; Jim Watters, SVP, Biology; Don Bergstrom, Head of R&D
*  Revance Therapeutics, Inc. (RVNC) - Dan Browne, President & CEO; Jeanie Herbert, IRO
*  Rodin Therapeutics (Private) - Adam Rosenberg, CEO; Ajim Tamboli CFO
*  RxSight (Private) - Ronald Kurtz, President and Chief Executive Officer
*  Sangamo Therapeutics (SGMO) - Sandy Macrae, President & CEO; Stephane Boissel, EVP, Corporate Strategy; McDavid Stilwell, VP, Corporate Communications & IR
*  SeaSpine Holdings Corp (SPNE) - Keith Valentine, CEO; John Bostjancic, CFO
*  Second Sight Medical (EYES) - Will McGuire, CEO; John Blake, CFO
*  Select Medical Holdings Corporation (SEM) -
Martin Jackson, CFO; Robert Ortenzio, Executive Chairman
*  Service Corp International (SCI) - Aaron Foley, Vice President and Treasurer; Debbie Young, Director of Investor Relations
*  Shockwave Medical Inc (SWAV) - Doug Godshall, CEO; Debbie Kaster, Investor Relations
*  SIGA Technologies, Inc. (SIGA) - Phil Gomez, PH.D, CEO; Dan Luckshire, CFO; Robin Abrams, General Counsel & CAO; Marianna Anesti, VP, Business Development & Corporate Strategy
*  Sunesis Pharmaceuticals (SNSS) - Dayton Misfeldt, CEO; William Quinn, CFO
*  Supernus Pharmaceuticals Inc. (SUPN) - Jack Khattar, CEO; Greg Patrick CFO; Peter Vozzo, IR
*  Tabula Rasa HealthCare Inc. (TRHC) - Brian Adams, CFO;  Andrea Speers, CAO
*  Teladoc, Inc. (TDOC) - Jason Gorevic, CEO; Mala Murthy, CFO
*  Teleflex, Inc. (TFX) - Liam Kelly, CEO; Jake Elguicze, Treasurer and Vice President, Investor Relations
*  Tenet Healthcare (THC) - Brendan Strong, VP, Investor Relations
*  Theravance Biopharma (TBPH) - Rick Winningham, Chairman & CEO; Andrew Hindman, SVP & CFO; Jessica Stitt, VP, Finance & IR
*  Titan Medical (TMD) - David McNally, President & CEO; Charles Federico, Chairman
Stephen Randall, CFO; Chad Zaring, Chief Commercial Officer
*  TRACON Pharmaceuticals, Inc. (TCON) - Charles Theuer, President & CEO; Scott Brown, Vice President, Finance
*  Triple-S Management (GTS) - Roberto Garcia-Rodriguez, CEO; Juan Jose Roman-Jimenez, CFO
*  UnitedHealth Group (UNH) - Andrew Witty, Office of the Chief Executive, EVP, UnitedHealth Group, Chief Executive Officer, Optum; John Rex, Executive Vice President and CFO; Brian Thompson, CEO, UnitedHealthcare Government Programs; Brett Manderfeld, SVP, Investor Relations
*  Universal Health Services (UHS) - Steve Filton, CFO
*  Veracyte (VCYT) - Bonnie Anderson, Chairman & CEO; Keith Kennedy, CFO
*  Vocera Communications, Inc. (VCRA) - Justin Spencer, CFO; Sue Dooley, VP, Investor Relations
*  Voyager Therapeutics, Inc. (VYGR) - Andre Turenne, CEO;  Allison Dorval, CFO; Omar Khwaja, CMO
*  Wright Medical Group N.V. (WMGI) - Robert Palmisano, President & CEO; Julie Dewey, Sr. VP, Chief Communications Officer
*  Xeris Pharmaceuticals (XERS) - Paul Edick, Chairman and CEO; Lance Berry, Exec VP, CFO & Operations Officer; Allison Wey, SVP, Investor Relations and Corp Comm
*  Zimmer Biomet Holdings Inc. (ZBH) - Cole Lannum, SVP of Investor Relations; Barbara Goslee, Director of Investor Relations
*  Zymeworks Inc. (ZYME) - Ali Tehrani, President & CEO;  

Registration

Register to attend by Friday, August 30

Reserve your hotel room by August 15

Hotel Location
The Westin Copley Place
10 Huntington Ave.
Boston, MA 02115
617-262-9600

Rate: $319 per night on a space available basis. Please call 617-262-9600 and reference the Wells Fargo Healthcare Conference when making your reservation.

Please note the Westin Copley Place block is full on select dates.  Please click here for some suggested nearby hotels

Key dates

August 2:
One-on-one requests due

August 9:
Companies to receive one-on-one schedules

August 16:
Investors to receive one-on-one schedules
 

Contact information

General inquiries
Deirdre Gilfeather
646-648-3945

deirdre.m.gilfeather
@wellsfargo.com